4
Participants
Start Date
May 31, 2008
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
Lenalidomide
10 mg by mouth daily
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Celgene Corporation
INDUSTRY
M.D. Anderson Cancer Center
OTHER